Gigabit Britain Moves Closer to a Reality as Call Flow Deploys ADTRAN-Powered 10Gbps FTTH Infrastructure
ADTRAN®, Inc., (NASDAQ: ADTN), a leading provider of next-generation open networking solutions, today announced that Call Flow has chosen its XGS-PON solution to power the UK’s first generation of symmetric multi-Gigabit Fibre-to-the-Home (FTTH) services. The rapidly-growing ultrafast broadband operator has already built out up to 100Mbps FTTC-based services across Southern England and, to allow services to scale, has now selected ADTRAN’s next generation 10Gbps FTTH solution. This new architecture, fully compatible with Call Flow’s existing FTTH network, is set to bring about a step-change in symmetric multi-Gigabit access performance to differentiate it from other providers as it targets strategic expansion over the next 5–10 years.
With new rapidly emerging application demands such as AR/VR, 4K media streaming and the cloudification of software applications, all driving increased demands for lower latency and higher data rates, service providers are urgently re-evaluating further investments in GPON as their standard of choice for new rollouts. ADTRAN is a pioneer in 10G PON solutions, providing the contributions that triggered the introduction of XGS-PON into the ITU standards. As the editor for this effort, ADTRAN drove industry consensus which resulted in the approval and adoption of the XGS-PON ITU standard.
By supporting 10Gbps symmetric fixed wavelength PON over new or existing fibre optic infrastructures, XGS-PON provides the optimal blend between performance and price, permitting Call Flow to address both residential and business subscribers simultaneously on a single, common optical distribution network. Essentially doubling the useable life span of the optical distribution network, ADTRAN’s XGS-PON solutions protects operators’ network investments, providing the available capacity to support premium revenues for years to come.
“Call Flow has a leading vision for multi-Gigabit broadband services to better enable their communities for the global marketplace and to improve individual customers’ lives. Its strategic choice of XGS-PON is foundational to its ambition to be a prominent FTTH player in the UK market,” said Ronan Kelly, CTO for EMEA & APAC at ADTRAN. “This deployment adds to the global momentum building around 10 Gigabit PON as the primary access technology of choice for operators in developed broadband markets. Rapidly and cost-effectively satisfying subscriber demand and government targets, XGS-PON is the breakthrough the FTTH industry has been waiting for.”
“ADTRAN’s global leadership in Gigabit broadband solutions made it the ideal choice to address the rising bandwidth demands we anticipate for the next 5–10 years and beyond,” said Andy Conibere, CEO at Call Flow. “Its commitment to modern software-based, open architectures reinforced our view that it was the right partner for us. As Call Flow expands to answer more of the pent-up demand for Gigabit broadband services throughout the UK, XGS-PON will be essential to future-proofing our competitive advantage and delivering maximum value to our residential and business customers, as well as our investors.”
ADTRAN, Inc. is a leading global provider of networking and communications equipment. ADTRAN’s products enable voice, data, video and Internet communications across a variety of network infrastructures. ADTRAN solutions are currently in use by service providers, private enterprises, government organizations, and millions of individual users worldwide. For more information, please visit www.adtran.com.
Call Flow is an innovative alternative network (alt-net) provider and has built both superfast and ultrafast networks across Kent, East Sussex, Hampshire and Berkshire. Call Flow is an industry leader in the use of Openreach’s ducts and poles (PIA/DPA) and Sub Loop Unbundling (SLU/FTTC). With several years experience of building innovative networks for various public bodies and BDUK, Call Flow is ideally placed to bring its skills to the fore in building 10 Gigabit PON networks in line with Government policy and Ofcom’s objective of infrastructure competition.
Cohesive for ADTRAN
Kate Anderson, +44 (0) 1291 626200
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00 | Pressemelding
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00 | Pressemelding
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26 | Pressemelding
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05 | Pressemelding
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03 | Pressemelding
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and